Novelmicrodevices
Portable PCR testing systems for clinics and decentralized healthcare settings
Highlights
- New on EvolcAdded 2026-11-13
About Novelmicrodevices
Novel Microdevices develops the Novel Dx, a battery-operated PCR system that runs a CT/NG/TV/MG panel in about 15 minutes. Its cartridge performs nucleic acid extraction on-board, and the device can connect over WiFi or cellular.
The system is intended for clinics and other decentralized settings seeking point-of-care molecular testing. The company says the platform is in development, is not available for clinical diagnostic use, and is expected to be offered for research use only beginning in Q4 2026.
The platform was evaluated at Emory University under NIH RADx funding. The listed open role is Research Associate, Assay V&V and Reagent Manufacturing Scale-Up in Baltimore, Maryland.
Product: A portable, battery-operated PCR instrument and single-use cartridges for molecular testing.
Jobs at Novelmicrodevices
More health & medtech companies
Nutexhealth
Healthcare operator running emergency hospitals and provider networks, with management services for physicians and affiliatesNew on EvolcNuvem
Pharmacy management, software and staffing for community health centers and other health providers in the USNew on EvolcOasis Ascent
Short-term residential mental health treatment for teens aged 12-17 and their families in Provo, UtahNew on EvolcOhMD
AI-powered patient communication and workflow software for medical practices and healthcare organizationsNew on EvolcOmada Health
Virtual care programs for employers and health plans to help members manage chronic conditions and improve healthNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-amz-cf-id
Recruiting
- BambooHRMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.